Market closed

Absci/$ABSI

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Ticker

$ABSI

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Vancouver, United States

Employees

155

Website

www.absci.com

Absci Metrics

BasicAdvanced

$327M

-

-$0.93

2.19 -

Price and volume

Market cap

$327M

Beta

2.19

52-week high

$6.72

52-week low

$2.45

Average daily volume

4.6M

Financial strength

Current ratio

5.626

Quick ratio

4.817

Long term debt to equity

3.478

Total debt to equity

5.955

Interest coverage (TTM)

-156.60%

Management effectiveness

Return on assets (TTM)

-27.40%

Return on equity (TTM)

-49.11%

Valuation

Price to revenue (TTM)

70.89

Price to book

1.62

Price to tangible book (TTM)

2.09

Price to free cash flow (TTM)

-4.215

Growth

Revenue change (TTM)

-39.35%

Earnings per share change (TTM)

-19.62%

3-year revenue growth (CAGR)

-11.44%

3-year earnings per share growth (CAGR)

-29.68%

What the Analysts think about Absci

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Absci stock.

Absci Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Absci Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Absci News

AllArticlesVideos

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Seeking Alpha·2 days ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

GlobeNewsWire·5 days ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

GlobeNewsWire·7 days ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ABSI

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Absci stock?

Absci (ABSI) has a market cap of $327M as of January 15, 2025.

What is the P/E ratio for Absci stock?

The price to earnings (P/E) ratio for Absci (ABSI) stock is 0 as of January 15, 2025.

Does Absci stock pay dividends?

No, Absci (ABSI) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Absci dividend payment date?

Absci (ABSI) stock does not pay dividends to its shareholders.

What is the beta indicator for Absci?

Absci (ABSI) has a beta rating of 2.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.